Sanofi Consumer Healthcare India Schedules Board Meeting to Approve Q3 Results
Sanofi Consumer Healthcare India Ltd 路 Intimation 路 28 Oct 2026, 5:30 am
Sanofi Consumer Healthcare India Schedules Board Meeting to Approve Q3 Results Sanofi Consumer Healthcare India Limited announced that its Board of Directors will meet on 28th Oct'26 to consider and approve the unaudited financial results for the quarter and nine months ended 30th Sep'26. Additionally, the trading window for designated persons, which closed on 1st Oct'26, will remain shut until 30th Oct'26 (both days inclusive) in accordance with insider trading regulations.
Original exchange filing (PDF)
More announcements from Sanofi Consumer Healthcare India Ltd
- Sanofi Consumer Healthcare India Limited has informed the Exchange regarding a press release dated October 28, 2026. 路 29 Oct 2026
- The Board of Directors at its meeting held on Wednesday, 28th October 2026, considered and approved the Unaudited Financial Results for the quarter and nine months ended 30th September .... 路 29 Oct 2026
- Sanofi Consumer Healthcare India Limited has submitted to the Exchange, the Unaudited Financial Results for the quarter and nine months ended September 30, 2026. 路 29 Oct 2026
- Unaudited Financial Results for the quarter and nine months ended September 30, 2026 is enclosed. 路 29 Oct 2026
- We wish to inform you that the Board of Directors at its meeting held today, i.e. Wednesday, 28th October 2026, inter alia considered and approved the Unaudited Financial Results for the .... 路 28 Oct 2026
- Sanofi Consumer Healthcare India Limited has informed the Exchange about Board Meeting to be held on 28-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 28 Oct 2026
- Sanofi Consumer Healthcare India Limited has informed the Exchange about Board Meeting to be held on 28-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 28 Oct 2026
- To consider and approve the Unaudited Financial Results for the quarter and nine months ended September 30, 2026 路 28 Oct 2026
